Foreword 
1. This system should also measure and publish information on the 
range of tar, nicotine, and carbon monoxide yields that most 
smokers should expect from each cigarette sold in the United 
States. 
2. This information should be clearly communicated to smokers. 
3. A simple graphic representation should be provided with each pack 
of cigarettes sold in the United States and in all advertisements. 
The representation should not imply a one-to-one relationship 
between measurements and disease risk. 
4. The system must be accompanied by public education to make 
smokers aware that individual exposure depends on how the 
cigarette is smoked and that the benefits of switching to lower 
yield cigarettes are small compared with quitting. 
D. There should be Federal oversight of cigarette testing, but such testing 
should continue to be performed by the tobacco industry and at 
industry expense. 
E. The questions involved in the purpose, methodology, and utility 
of the FTC protocol are complex medical and scientific issues that 
require ongoing involvement of Federal health agencies, including 
the National Institutes of Health, the Food and Drug Administration, 
and the Centers for Disease Control and Prevention. 
F. The system should be reexamined at least every 5 years to evaluate 
whether the protocol is maintaining its utility to the smoker. 
G. When a cigarette manufacturer makes significant changes in cigarette 
design that affect yields, it should notify the appropriate Federal 
agency. 
II. With regard to the second question, the committee recommends that to 
avoid confusing smokers, no smoke constituents other than tar, nicotine, 
and carbon monoxide be measured and published at the present time. 
Smokers should be informed of the presence of other hazardous smoke 
constituents with each package and with all advertisements. These 
constituents should be classified by toxic effects. 
III. In considering the third question, the committee reached the following 
conclusions: 
A. Information from the testing system is useless to smokers unless 
they have ready access to it. The information from the testing system 
should be made available to all smokers, including those who smoke 
generic brands and other brands not widely advertised. 
B. Brand names and brand classifications such as "light" and "ultralight" 
represent health claims and should be regulated and accompanied, in 
fair balance, with an appropriate disclaimer. 
vii 
